Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Mar;50(3):492–499. doi: 10.1172/JCI106517

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

Eduardo Slatopolsky 1,2, Sali Caglar 1,2, J P Pennell 1,2, Dennis D Taggart 1,2, Janet M Canterbury 1,2, Eric Reiss 1,2, Neal S Bricker 1,2
PMCID: PMC291955  PMID: 5545116

Abstract

Healthy adult dogs were subjected to stepwise reduction of nephron population so as to create the transition from normal renal function to advanced renal insufficiency. Studies were performed at each level of renal function. Glomerular filtration rate (GFR), renal phosphate clearance, and serum radioimmunoassayable parathyroid hormone (PTH) levels were measured. Two groups of animals were studied. In one, phosphorous intake was maintained at 1200 mg/day. As GFR declined, fractional phosphate excretion rose reciprocally, and PTH levels increased over 20-fold. In the second group, phosphorous intake was maintained at less than 100 mg/day. As GFR fell, fractional phosphate excretion changed little, and no increment in PTH levels occurred. The data suggest that the control system regulating phosphate excretion contributes importantly to the pathogenesis of secondary hyperparathyroidism in advancing renal insufficiency.

Full text

PDF
492

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avioli L. V., Birge S., Lee S. W., Slatopolsky E. The metabolic fate of vitamin D3-3H in chronic renal failure. J Clin Invest. 1968 Oct;47(10):2239–2252. doi: 10.1172/JCI105909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berson S. A., Yalow R. S., Aurbach G. D., Potts J. T. IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A. 1963 May;49(5):613–617. doi: 10.1073/pnas.49.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berson S. A., Yalow R. S. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science. 1966 Nov 18;154(3751):907–909. doi: 10.1126/science.154.3751.907. [DOI] [PubMed] [Google Scholar]
  4. Bricker N. S., Slatopolsky E., Reiss E., Avioli L. V. Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med. 1969 May;123(5):543–553. [PubMed] [Google Scholar]
  5. DENT C. E., HARPER C. M., PHILPOT G. R. The treatment of renal-glomerular osteodystrophy. Q J Med. 1961 Jan;30:1–31. [PubMed] [Google Scholar]
  6. Kleeman C. R., Better O., Massry S. G., Maxwell M. H. Divalent ion metabolism and osteodystrophy in chronic renal failure. Yale J Biol Med. 1967 Aug 1;40(1):1–45. [PMC free article] [PubMed] [Google Scholar]
  7. Moore E. W. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J Clin Invest. 1970 Feb;49(2):318–334. doi: 10.1172/JCI106241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. POLLAK V. E., SCHNEIDER A. F., FREUND G., KARK R. M. Chronic renal disease with secondary hyperparathyroidism. AMA Arch Intern Med. 1959 Feb;103(2):200–218. doi: 10.1001/archinte.1959.00270020028004. [DOI] [PubMed] [Google Scholar]
  9. Reis E., Canterbury J. M. A radioimmunoassay for parathyroid hormone in man. Proc Soc Exp Biol Med. 1968 Jun;128(2):501–504. doi: 10.3181/00379727-128-33050. [DOI] [PubMed] [Google Scholar]
  10. Reiss E., Canterbury J. M. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med. 1969 Jun 19;280(25):1381–1385. doi: 10.1056/NEJM196906192802504. [DOI] [PubMed] [Google Scholar]
  11. Reiss E., Canterbury J. M., Bercovitz M. A., Kaplan E. L. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest. 1970 Nov;49(11):2146–2149. doi: 10.1172/JCI106432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reiss E., Canterbury J. M., Egdahl R. H. Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians. 1968;81:104–115. [PubMed] [Google Scholar]
  13. STANBURY S. W. Azotaemic renal osteodystrophy. Br Med Bull. 1957 Jan;13(1):57–60. doi: 10.1093/oxfordjournals.bmb.a069572. [DOI] [PubMed] [Google Scholar]
  14. Schultze R. G., Shapiro H. S., Bricker N. S. Studies on the control of sodium excretion in experimental uremia. J Clin Invest. 1969 May;48(5):869–877. doi: 10.1172/JCI106045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sherwood L. M., Mayer G. P., Ramberg C. F., Jr, Kronfeld D. S., Aurbach G. D., Potts J. T., Jr Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology. 1968 Nov;83(5):1043–1051. doi: 10.1210/endo-83-5-1043. [DOI] [PubMed] [Google Scholar]
  16. Slatopolsky E., Gradowska L., Kashemsant C., Keltner R., Manley C., Bricker N. S. The control of phosphate excretion in uremia. J Clin Invest. 1966 May;45(5):672–677. doi: 10.1172/JCI105382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Slatopolsky E., Robson A. M., Elkan I., Bricker N. S. Control of phosphate excretion in uremic man. J Clin Invest. 1968 Aug;47(8):1865–1874. doi: 10.1172/JCI105877. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES